KDx Diagnostics
Pre-clinicalKDx Diagnostics Inc. (KDx) is a developer of novel diagnostic tests that improve early detection and management of cancer.
Founded
2018
Focus
Diagnostics
About
KDx Diagnostics Inc. (KDx) is a developer of novel diagnostic tests that improve early detection and management of cancer.
Funding History
2Total raised: $17M
Series A$15MBios PartnersMay 15, 2022
Grant$2MNational Institutes of HealthJun 15, 2020
Company Info
TypePrivate
Founded2018
LocationSan Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile